HAVCR1 and chronic kidney disease: In this cross-sectional investigation, we assessed urinary cadmium concentrations in non-dialysis-dependent CKD patients and utilized ELISA-measured renal biomarkers, including urinary KIM-1, 8-OHdG, and EGF, to evaluate cadmium-associated renal injury in this population.